Di Salle E - Search Results

1

Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women.

Evans TR, Di Salle E, Ornati G, Lassus M, Benedetti MS, Pianezzola E, Coombes RC. Evans TR, et al. Among authors: di salle e. Cancer Res. 1992 Nov 1;52(21):5933-9. Cancer Res. 1992. PMID: 1394219 Clinical Trial.

2

Exemestane (FCE 24304), a new steroidal aromatase inhibitor.

di Salle E, Ornati G, Giudici D, Lassus M, Evans TR, Coombes RC. di Salle E, et al. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):137-43. doi: 10.1016/0960-0760(92)90198-r. J Steroid Biochem Mol Biol. 1992. PMID: 1525055 Review.

3

In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.

Geisler J, King N, Anker G, Ornati G, Di Salle E, Lønning PE, Dowsett M. Geisler J, et al. Among authors: di salle e. Clin Cancer Res. 1998 Sep;4(9):2089-93. Clin Cancer Res. 1998. PMID: 9748124 Clinical Trial.

4

Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study.

Johannessen DC, Engan T, Di Salle E, Zurlo MG, Paolini J, Ornati G, Piscitelli G, Kvinnsland S, Lonning PE. Johannessen DC, et al. Among authors: di salle e. Clin Cancer Res. 1997 Jul;3(7):1101-8. Clin Cancer Res. 1997. PMID: 9815789 Clinical Trial.

5

Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours.

Zaccheo T, Giudici D, Ornati G, Panzeri A, di Salle E. Zaccheo T, et al. Among authors: di salle e. Eur J Cancer. 1991;27(9):1145-50. doi: 10.1016/0277-5379(91)90313-3. Eur J Cancer. 1991. PMID: 1835626

6

4-Aminoandrostenedione derivatives: a novel class of irreversible aromatase inhibitors. Comparison with FCE 24304 and 4-hydroxyandrostenedione.

Di Salle E, Giudici D, Ornati G, Briatico G, D'Alessio R, Villa V, Lombardi P. Di Salle E, et al. J Steroid Biochem Mol Biol. 1990 Nov 20;37(3):369-74. doi: 10.1016/0960-0760(90)90486-5. J Steroid Biochem Mol Biol. 1990. PMID: 2257240

7

Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.

di Salle E, Briatico G, Giudici D, Ornati G, Zaccheo T. di Salle E, et al. J Steroid Biochem. 1989;34(1-6):431-4. doi: 10.1016/0022-4731(89)90122-2. J Steroid Biochem. 1989. PMID: 2516584

8

6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor.

Giudici D, Ornati G, Briatico G, Buzzetti F, Lombardi P, di Salle E. Giudici D, et al. Among authors: di salle e. J Steroid Biochem. 1988;30(1-6):391-4. doi: 10.1016/0022-4731(88)90129-x. J Steroid Biochem. 1988. PMID: 3386266

9

New endocrine agents for the treatment of breast cancer.

Coombes RC, Jarman M, Dowsett M, Chander SK, Rowlands MG, Di Salle E, Evans TJ. Coombes RC, et al. Among authors: di salle e. Recent Results Cancer Res. 1993;127:267-75. doi: 10.1007/978-3-642-84745-5_35. Recent Results Cancer Res. 1993. PMID: 8502825 Review. No abstract available.

10

Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study.

Paridaens R, Thomas J, Wildiers J, Vermeiren P, Lobelle JP, di Salle E, Ornati G, Zurlo MG, Polli A, Lanzalone S, de Belder K. Paridaens R, et al. Among authors: di salle e. Anticancer Drugs. 1998 Sep;9(8):675-83. doi: 10.1097/00001813-199809000-00002. Anticancer Drugs. 1998. PMID: 9823425 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters